Frontiers in Medicine (Sep 2022)

Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients

  • Assaf Gershoni,
  • Assaf Gershoni,
  • Edward Barayev,
  • Edward Barayev,
  • Doha Jbara,
  • Doha Jbara,
  • Amir Hadayer,
  • Amir Hadayer,
  • Ruth Axer-Siegel,
  • Ruth Axer-Siegel,
  • Assaf Dotan,
  • Assaf Dotan,
  • Orly Gal-Or,
  • Orly Gal-Or,
  • Raimo Tuuminen,
  • Raimo Tuuminen,
  • Rita Ehrlich,
  • Rita Ehrlich

DOI
https://doi.org/10.3389/fmed.2022.978346
Journal volume & issue
Vol. 9

Abstract

Read online

PurposeTo compare intra- and postoperative complications in combined phacoemulsification and pars plana vitrectomy surgeries performed in patients with non-proliferative diabetic retinopathy (NPDR) vs. proliferative diabetic retinopathy (PDR).MethodsRetrospective, case series of patients with diabetic retinopathy who underwent combined phacovitrectomy surgery between 2008 and 2017. We compared intraoperative complications including posterior capsular rupture and retinal tear, and postoperative complications including corneal edema, macular edema (ME), epiretinal membrane (ERM), neovascular glaucoma and persistent inflammation.ResultsA total of 104 eyes of 104 patients were included in this study. Twenty-four eyes (23.1%) were categorized as NPDR and 80 eyes (76.9%) as PDR. The most common indications for surgery in the NPDR group were ERM (67%) and rhegmatogenous retinal detachment (12.5%), while in the PDR group, indications were vitreous hemorrhage (56%) and tractional retinal detachment (19%). The most common intraoperative complication was retinal tear (8% in NPDR and 19% in PDR, p = 0.195) and postoperative complication was ME (29% in NPDR and 26% in PDR, p = 0.778). There were no statistically significant differences in intra- and postoperative complication rates between the NPDR and PDR groups, even after adjusting for confounders; patient age at surgery and indication for surgery.ConclusionAfter combined phacovitrectomy in NPDR and PDR patients, new-onset ME was found in about a quarter of eyes in both groups. Intraoperative anti-VEGF or steroid administration, and intense postoperative anti-inflammatory medication and follow-up should be regarded after phacovitrectomy regardless of the DR level.

Keywords